Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-150 in Osteoarthritis of the Knee
NCT02660424Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Dec 2015
- Primary completion
- Aug 2016
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VX-150 in osteoarthritis (OA), sponsored by Vertex Pharmaceuticals. Started Dec 2015; status: completed.
02
Drugs
VX-150
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02660424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660424.